Spinocerebellar Ataxia, Ataxin 10 (ATXN10) Gene Mutation Analysis
Spinocerebellar ataxias (SCAs) represent a genetically and clinically heterogeneous group of autosomal dominant neurodegenerative disorders characterized by progressive cerebellar dysfunction, leading to gait ataxia, dysarthria, and impaired coordination. Spinocerebellar Ataxia Type 10 (SCA10) is caused by an ATTCT pentanucleotide repeat expansion in intron 9 of the ATXN10 gene on chromosome 22q13.31. This expansion disrupts normal gene function and produces toxic RNA-mediated effects that contribute to neuronal degeneration within the cerebellum and brainstem.
Clinically, SCA10 is characterized by progressive ataxia, dysarthria, and seizures, with a reported age of onset ranging from 12 to 83 years. Recurrent epileptic seizures occur in 20–100% of affected individuals, depending on repeat length and genetic background. The disease exhibits variable penetrance and expressivity, correlating with the degree of expansion.
Genetic testing of the ATXN10 gene for repeat expansion is the gold standard for diagnosis and confirmation of SCA10. Early molecular identification supports accurate diagnosis, risk assessment, and genetic counseling for family members.
- Confirms diagnosis of spinocerebellar ataxia type 10 (SCA10)
- Assists in carrier detection and predictive testing for at-risk relatives
- Provides genetic information for prognosis, recurrence risk, and genetic counseling
Repeat Range Interpretation / Clinical Significance
10–32 ATTCT repeats Normal alleles
33–280 ATTCT repeats Intermediate alleles of uncertain significance
800–4500 ATTCT repeats Pathogenic expansion – full penetrance associated with SCA10
Repeat length correlates with disease penetrance and severity. Alleles in the intermediate range may or may not be clinically significant and should be interpreted in conjunction with family history and clinical features.
10–32 ATTCT allele repeats (normal range)
Polymerase Chain Reaction (PCR) and Southern Blot are performed sequentially or concurrently for accurate sizing and detection of ATTCT repeat expansions. Other technology used, next generation sequencing, Bi-directional sanger sequencing, repeat expansion detection by PCR, gel electrophoresis, deletion/duplication analysis.
Whole blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- J Neurol. 2025 Mar 11;272(4):261. [PMID: 40067487]
- Cerebellum. 2005;4(1):37-42. [PMID: 15895557]
- Am J Hum Genet. 2004 Jun;74(6):1216-24. [PMID: 15127363]
- Arq Neuropsiquiatr. 2015 Aug;73(8):725-7. [PMID: 26222367]
- Neurol Sci. 2022 Nov;43(11):6623. [PMID: 35469073]
- Cerebellum. 2019 Oct;18(5):849-854. [PMID: 31377949]